Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Significantly better success rates were noted in patients receiving four repeated injections and three injections compared to a single injection [41].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [41]
In the citing paper
“The efficacy of repeat BoNT-A injections with hydrodistension in improving bladder pain and maximal bladder capacity has previously been demonstrated [41].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 30
- Hanno, 2001, Clinical highlights of the national Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis, Urology, 57, 2, 10.1016/S0090-4295(01)01112-8 · DOI
- Shie, 2011, Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome, BJU Int, 108, E136, 10.1111/j.1464-410X.2010.09911.x · DOI · Paper page
- Brady, 2004, Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment, BJU Int, 93, 770, 10.1111/j.1464-410X.2003.04722.x · doi:10.1111/j.1464-410x.2003.04722.x
- Cockayne, 2000, Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice, Nature, 407, 1011, 10.1038/35039519 · DOI · Paper page
- Cayan, 2003, Botulinum toxin type A may improve bladder function in a rat chemical cystitis model, Urol Res, 30, 399, 10.1007/s00240-002-0291-0 · DOI
- Steers, 2006, Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders, Nat Clin Pract Urol, 3, 101, 10.1038/ncpuro0408 · DOI · Paper page
- Rapp, 2006, Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder, J Urol, 175, 1138, 10.1016/S0022-5347(05)00322-8 · doi:10.1016/s0022-5347(05)00322-8
- Chuang, 2004, Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain response in rats, J Urol, 172, 1529, 10.1097/01.ju.0000137844.77524.97 · DOI · Paper page
- Giannantoni, 2006, Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity, J Urol, 175, 2341, 10.1016/S0022-5347(06)00258-8 · DOI
- Khera, 2004, Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury, Neurochem Int, 45, 987, 10.1016/j.neuint.2004.06.001 · doi:10.1016/j.neuint.2004.06.001
- Apostolidis, 2005, Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injection of botulinum A toxin for human detrusor overactivity, J Urol, 173, 977, 10.1097/01.ju.0000169481.42259.54 · doi:10.1097/01.ju.0000169481.42259.54
- Reitz, 2004, European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity, Eur Urol, 45, 510, 10.1016/j.eururo.2003.12.004 · doi:10.1016/j.eururo.2003.12.004
- Smith, 2004, Botulinum toxin A has antinociceptive effects in treating interstitial cystitis, Urology, 64, 871, 10.1016/j.urology.2004.06.073 · doi:10.1016/j.urology.2004.06.073
- Kuo, 2005, Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis, Urol Int, 75, 170, 10.1159/000087173 · DOI
- Giannantoni, 2006, Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study, Eur Urol, 49, 704, 10.1016/j.eururo.2005.12.002 · DOI
- Cui, 2000, Botulinum toxin type A (BTX-A) reduces inflammatory pain in the rat formalin model, Cephalalgia, 20, 414
- Giannantoni, 2008, Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup, J Urol, 179, 1031, 10.1016/j.juro.2007.10.032 · DOI
- Hanno, 1998, Campbell's Urology, 631
- NIDDK workshop of interstitial cystitis Besthesda, Maryland, USA 1987
- Lubeck, 2001, Psychometric validation of the O'Leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium, Urology, 57, 62, 10.1016/S0090-4295(01)01126-8 · DOI
- Nickel, 2005, Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis, Urology, 65, 654, 10.1016/j.urology.2004.10.071 · DOI · Paper page
- Sant, 2003, A pilot clinical trial of oral pentosan polysulphate and oral hydroxyzine in patients with interstitial cystitis, J Urol, 170, 810, 10.1097/01.ju.0000083020.06212.3d · DOI · Paper page
- Abrams, 2002, The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society, Neurourol Urodyn, 21, 167, 10.1002/nau.10052 · DOI · Paper page
- Parsons, 2009, The potassium sensitivity test: a new gold standard for diagnosing and understanding the pathophysiology of interstitial cystitis, J Urol, 182, 432
- Kuo, 2009, Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome, BJU Int, 104, 657, 10.1111/j.1464-410X.2009.08495.x · DOI · Paper page
- Cui, 2004, Subcutaneous administration of botulinum toxin A reduces formalin-induced pain, Pain, 107, 125, 10.1016/j.pain.2003.10.008 · DOI · Paper page
- Liu, 2007, Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis, Urology, 70, 463, 10.1016/j.urology.2007.04.038 · DOI · Paper page
- Pinto, 2010, Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis, Eur Urol, 58, 360, 10.1016/j.eururo.2010.02.031 · DOI · Paper page
- Yamada, 2007, Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients, World J Urol, 25, 407, 10.1007/s00345-007-0174-7 · doi:10.1007/s00345-007-0174-7
- Kiuchi, 2009, Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/ interstitial cystitis: its association with pain severity and glomerulations, BJU Int, 104, 826, 10.1111/j.1464-410X.2009.08467.x · doi:10.1111/j.1464-410x.2009.08467.x
Cited by
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment
Hanno, P. M., Erickson, D., Moldwin, R., & Faraday, M. M. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.01.086 · Cited by 692
Possible pathophysiology of ketamine‐related cystitis and associated treatment strategies
Jhang, J., Hsu, Y., & Kuo, H. (2015) · International Journal of Urology · doi:10.1111/iju.12841 · Cited by 106
Self-citationYu, W.-R., Jhang, J.-F., Jiang, Y.-H., & Kuo, H.-C. (2024) · Biomedicines · doi:10.3390/biomedicines12092051 · Cited by 39
Self-citationThe enigma of men with interstitial cystitis/bladder pain syndrome.
Arora, H. C., & Shoskes, D. A. (2015) · PubMed Central · doi:10.3978/j.issn.2223-4683.2015.10.01 · Cited by 30
Metadata
- Authors
- Kuo, H.-C.
- Affiliations
- Department of Urology; Buddhist Tzu Chi General Hospital and Tzu Chi University; Hualien Taiwan
- Venue
- International Journal of Clinical Practice
- Publisher
- Hindawi Limited
- Published
- 2013-04-11
- Volume
- 67
- Issue
- 5
- Pages
- 427-434
- ISSN
- 1368-5031
- Cited by
- 31
- References
- 0
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 873 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome. https://app.cochat.ai/papers/10.1111/ijcp.12113
- The paper
- Kuo, H.-C. (2013). Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome. International Journal of Clinical Practice. https://doi.org/10.1111/ijcp.12113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.